APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Aurora Kinase B

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Aurora Kinase B Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173968300319 December 2025188 pages

Choose your research edition.

Industry ResearchAurora Kinase B Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Aurora Kinase B Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Aurora Kinase B Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Aurora Kinase B Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Aurora Kinase B Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Aurora Kinase B market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Aurora Kinase B is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Aurora Kinase B is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Aurora Kinase B is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Aurora Kinase B is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Aurora Kinase B include Advenchen Laboratories LLC, Aeterna Zentaris Inc, Chipscreen Biosciences Ltd, Cielo Therapeutics Inc, Sareum Holdings Plc, AstraZeneca Plc, AbbVie Inc, Amgen Inc and Sanofi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Aurora Kinase B market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Aurora Kinase B and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Aurora Kinase B sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Aurora Kinase B market size, projected growth trends, production technologies, key applications, and end-use industries.

Aurora Kinase B Segment by Company

Advenchen Laboratories LLC

Aeterna Zentaris Inc

Chipscreen Biosciences Ltd

Cielo Therapeutics Inc

Sareum Holdings Plc

AstraZeneca Plc

AbbVie Inc

Amgen Inc

Sanofi

Aurora Kinase B Segment by Type

Danusertib

NMI-900

Ilorasertib

CS-2164

AZD-2811

Others

Aurora Kinase B Segment by Application

Kidney Cancer

Prostate Cancer

Anaplastic Large Cell Lymphoma

Lung Cancer

Others

Aurora Kinase B Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Aurora Kinase B market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Aurora Kinase B and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Aurora Kinase B.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Aurora Kinase B market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Aurora Kinase B manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Aurora Kinase B in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Aurora Kinase B in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Aurora Kinase B Industry Trends Table 2. Aurora Kinase B Industry Drivers Table 3. Aurora Kinase B Industry Opportunities and Challenges Table 4. Aurora Kinase B Industry Restraints Table 5. Global Aurora Kinase B Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Aurora Kinase B Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Aurora Kinase B Sales by Manufacturers (W Units) & (2021-2026) Table 8. Global Aurora Kinase B Sales Market Share by Manufacturers Table 9. Global Aurora Kinase B Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Aurora Kinase B Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Aurora Kinase B Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Aurora Kinase B Manufacturers, Product Type & Application Table 13. Global Aurora Kinase B Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Aurora Kinase B by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Danusertib Table 17. Major Manufacturers of NMI-900 Table 18. Major Manufacturers of Ilorasertib Table 19. Major Manufacturers of CS-2164 Table 20. Major Manufacturers of AZD-2811 Table 21. Major Manufacturers of Others Table 22. Global Aurora Kinase B Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 23. Global Aurora Kinase B Sales by Type (2021-2026) & (W Units) Table 24. Global Aurora Kinase B Sales by Type (2027-2032) & (W Units) Table 25. Global Aurora Kinase B Sales Market Share by Type (2021-2026) Table 26. Global Aurora Kinase B Sales Market Share by Type (2027-2032) Table 27. Global Aurora Kinase B Revenue by Type 2021 VS 2025 VS 2032 (W Units) Table 28. Global Aurora Kinase B Revenue by Type (2021-2026) & (W Units) Table 29. Global Aurora Kinase B Revenue by Type (2027-2032) & (W Units) Table 30. Global Aurora Kinase B Revenue Market Share by Type (2021-2026) Table 31. Global Aurora Kinase B Revenue Market Share by Type (2027-2032) Table 32. Major Manufacturers of Kidney Cancer Table 33. Major Manufacturers of Prostate Cancer Table 34. Major Manufacturers of Anaplastic Large Cell Lymphoma Table 35. Major Manufacturers of Lung Cancer Table 36. Major Manufacturers of Others Table 37. Global Aurora Kinase B Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 38. Global Aurora Kinase B Sales by Application (2021-2026) & (W Units) Table 39. Global Aurora Kinase B Sales by Application (2027-2032) & (W Units) Table 40. Global Aurora Kinase B Sales Market Share by Application (2021-2026) Table 41. Global Aurora Kinase B Sales Market Share by Application (2027-2032) Table 42. Global Aurora Kinase B Revenue by Application 2021 VS 2025 VS 2032 (W Units) Table 43. Global Aurora Kinase B Revenue by Application (2021-2026) & (W Units) Table 44. Global Aurora Kinase B Revenue by Application (2027-2032) & (W Units) Table 45. Global Aurora Kinase B Revenue Market Share by Application (2021-2026) Table 46. Global Aurora Kinase B Revenue Market Share by Application (2027-2032) Table 47. Global Aurora Kinase B Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 48. Global Aurora Kinase B Sales by Region (2021-2026) & (W Units) Table 49. Global Aurora Kinase B Sales Market Share by Region (2021-2026) Table 50. Global Aurora Kinase B Sales Forecasted by Region (2027-2032) & (W Units) Table 51. Global Aurora Kinase B Sales Forecasted Market Share by Region (2027-2032) Table 52. North America Aurora Kinase B Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 53. North America Aurora Kinase B Sales by Country (2021-2026) & (W Units) Table 54. North America Aurora Kinase B Sales by Country (2027-2032) & (W Units) Table 55. Europe Aurora Kinase B Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 56. Europe Aurora Kinase B Sales by Country (2021-2026) & (W Units) Table 57. Europe Aurora Kinase B Sales by Country (2027-2032) & (W Units) Table 58. Asia Pacific Aurora Kinase B Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 59. Asia Pacific Aurora Kinase B Sales by Country (2021-2026) & (W Units) Table 60. Asia Pacific Aurora Kinase B Sales by Country (2027-2032) & (W Units) Table 61. South America, Middle East and Africa Aurora Kinase B Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 62. South America, Middle East and Africa Aurora Kinase B Sales by Country (2021-2026) & (W Units) Table 63. South America, Middle East and Africa Aurora Kinase B Sales by Country (2027-2032) & (W Units) Table 64. Global Aurora Kinase B Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 65. Global Aurora Kinase B Revenue by Region (2021-2026) & (US$ Million) Table 66. Global Aurora Kinase B Revenue by Region (2027-2032) & (US$ Million) Table 67. Global Aurora Kinase B Revenue Market Share by Region (2021-2026) Table 68. Global Aurora Kinase B Revenue Market Share by Region (2027-2032) Table 69. Advenchen Laboratories LLC Company Information Table 70. Advenchen Laboratories LLC Business Overview Table 71. Advenchen Laboratories LLC Aurora Kinase B Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Advenchen Laboratories LLC Aurora Kinase B Product Portfolio Table 73. Advenchen Laboratories LLC Recent Development Table 74. Aeterna Zentaris Inc Company Information Table 75. Aeterna Zentaris Inc Business Overview Table 76. Aeterna Zentaris Inc Aurora Kinase B Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Aeterna Zentaris Inc Aurora Kinase B Product Portfolio Table 78. Aeterna Zentaris Inc Recent Development Table 79. Chipscreen Biosciences Ltd Company Information Table 80. Chipscreen Biosciences Ltd Business Overview Table 81. Chipscreen Biosciences Ltd Aurora Kinase B Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Chipscreen Biosciences Ltd Aurora Kinase B Product Portfolio Table 83. Chipscreen Biosciences Ltd Recent Development Table 84. Cielo Therapeutics Inc Company Information Table 85. Cielo Therapeutics Inc Business Overview Table 86. Cielo Therapeutics Inc Aurora Kinase B Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Cielo Therapeutics Inc Aurora Kinase B Product Portfolio Table 88. Cielo Therapeutics Inc Recent Development Table 89. Sareum Holdings Plc Company Information Table 90. Sareum Holdings Plc Business Overview Table 91. Sareum Holdings Plc Aurora Kinase B Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Sareum Holdings Plc Aurora Kinase B Product Portfolio Table 93. Sareum Holdings Plc Recent Development Table 94. AstraZeneca Plc Company Information Table 95. AstraZeneca Plc Business Overview Table 96. AstraZeneca Plc Aurora Kinase B Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. AstraZeneca Plc Aurora Kinase B Product Portfolio Table 98. AstraZeneca Plc Recent Development Table 99. AbbVie Inc Company Information Table 100. AbbVie Inc Business Overview Table 101. AbbVie Inc Aurora Kinase B Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. AbbVie Inc Aurora Kinase B Product Portfolio Table 103. AbbVie Inc Recent Development Table 104. Amgen Inc Company Information Table 105. Amgen Inc Business Overview Table 106. Amgen Inc Aurora Kinase B Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Amgen Inc Aurora Kinase B Product Portfolio Table 108. Amgen Inc Recent Development Table 109. Sanofi Company Information Table 110. Sanofi Business Overview Table 111. Sanofi Aurora Kinase B Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Sanofi Aurora Kinase B Product Portfolio Table 113. Sanofi Recent Development Table 114. Key Raw Materials Table 115. Raw Materials Key Suppliers Table 116. Aurora Kinase B Distributors List Table 117. Aurora Kinase B Customers List Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Aurora Kinase B Product Image Figure 2. Global Aurora Kinase B Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Aurora Kinase B Market Size (2021-2032) & (US$ Million) Figure 4. Global Aurora Kinase B Sales (2021-2032) & (W Units) Figure 5. Global Aurora Kinase B Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Aurora Kinase B Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Danusertib Image Figure 9. NMI-900 Image Figure 10. Ilorasertib Image Figure 11. CS-2164 Image Figure 12. AZD-2811 Image Figure 13. Others Image Figure 14. Global Aurora Kinase B Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 15. Global Aurora Kinase B Sales Market Share 2021 VS 2025 VS 2032 Figure 16. Global Aurora Kinase B Sales Market Share by Type (2021-2032) Figure 17. Global Aurora Kinase B Revenue by Type (2021 VS 2025 VS 2032) & (W Units) Figure 18. Global Aurora Kinase B Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Aurora Kinase B Revenue Market Share by Type (2021-2032) Figure 20. Kidney Cancer Image Figure 21. Prostate Cancer Image Figure 22. Anaplastic Large Cell Lymphoma Image Figure 23. Lung Cancer Image Figure 24. Others Image Figure 25. Global Aurora Kinase B Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 26. Global Aurora Kinase B Sales Market Share 2021 VS 2025 VS 2032 Figure 27. Global Aurora Kinase B Sales Market Share by Application (2021-2032) Figure 28. Global Aurora Kinase B Revenue by Application (2021 VS 2025 VS 2032) & (W Units) Figure 29. Global Aurora Kinase B Revenue Market Share 2021 VS 2025 VS 2032 Figure 30. Global Aurora Kinase B Revenue Market Share by Application (2021-2032) Figure 31. North America Aurora Kinase B Sales and Growth Rate (2021-2032) & (W Units) Figure 32. North America Aurora Kinase B Sales Market Share by Country (2021-2032) Figure 33. U.S. Aurora Kinase B Sales and Growth Rate (2021-2032) & (W Units) Figure 34. Canada Aurora Kinase B Sales and Growth Rate (2021-2032) & (W Units) Figure 35. Mexico Aurora Kinase B Sales and Growth Rate (2021-2032) & (W Units) Figure 36. Europe Aurora Kinase B Sales and Growth Rate (2021-2032) & (W Units) Figure 37. Europe Aurora Kinase B Sales Market Share by Country (2021-2032) Figure 38. Germany Aurora Kinase B Sales and Growth Rate (2021-2032) & (W Units) Figure 39. France Aurora Kinase B Sales and Growth Rate (2021-2032) & (W Units) Figure 40. U.K. Aurora Kinase B Sales and Growth Rate (2021-2032) & (W Units) Figure 41. Italy Aurora Kinase B Sales and Growth Rate (2021-2032) & (W Units) Figure 42. Netherlands Aurora Kinase B Sales and Growth Rate (2021-2032) & (W Units) Figure 43. Asia Pacific Aurora Kinase B Sales and Growth Rate (2021-2032) & (W Units) Figure 44. Asia Pacific Aurora Kinase B Sales Market Share by Country (2021-2032) Figure 45. China Aurora Kinase B Sales and Growth Rate (2021-2032) & (W Units) Figure 46. Japan Aurora Kinase B Sales and Growth Rate (2021-2032) & (W Units) Figure 47. South Korea Aurora Kinase B Sales and Growth Rate (2021-2032) & (W Units) Figure 48. Southeast Asia Aurora Kinase B Sales and Growth Rate (2021-2032) & (W Units) Figure 49. India Aurora Kinase B Sales and Growth Rate (2021-2032) & (W Units) Figure 50. Australia Aurora Kinase B Sales and Growth Rate (2021-2032) & (W Units) Figure 51. South America, Middle East and Africa Aurora Kinase B Sales and Growth Rate (2021-2032) & (W Units) Figure 52. South America, Middle East and Africa Aurora Kinase B Sales Market Share by Country (2021-2032) Figure 53. Brazil Aurora Kinase B Sales and Growth Rate (2021-2032) & (W Units) Figure 54. South Africa Aurora Kinase B Sales and Growth Rate (2021-2032) & (W Units) Figure 55. Saudi Arabia Aurora Kinase B Sales and Growth Rate (2021-2032) & (W Units) Figure 56. Turkey Aurora Kinase B Sales and Growth Rate (2021-2032) & (W Units) Figure 57. Argentina Aurora Kinase B Sales and Growth Rate (2021-2032) & (W Units) Figure 58. UAE Aurora Kinase B Sales and Growth Rate (2021-2032) & (W Units) Figure 59. Egypt Aurora Kinase B Sales and Growth Rate (2021-2032) & (W Units) Figure 60. Chile Aurora Kinase B Sales and Growth Rate (2021-2032) & (W Units) Figure 61. Global Aurora Kinase B Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Global Aurora Kinase B Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 63. North America Aurora Kinase B Revenue (2021-2032) & (US$ Million) Figure 64. North America Aurora Kinase B Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Europe Aurora Kinase B Revenue (2021-2032) & (US$ Million) Figure 66. Europe Aurora Kinase B Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Asia-Pacific Aurora Kinase B Revenue (2021-2032) & (US$ Million) Figure 68. Asia-Pacific Aurora Kinase B Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. South America, Middle East and Africa Aurora Kinase B Revenue (2021-2032) & (US$ Million) Figure 70. South America, Middle East and Africa Aurora Kinase B Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 71. Aurora Kinase B Value Chain Figure 72. Manufacturing Cost Structure Figure 73. Aurora Kinase B Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • Danusertib
  • NMI-900
  • Ilorasertib
  • CS-2164
  • AZD-2811
  • Others
Applications
  • Kidney Cancer
  • Prostate Cancer
  • Anaplastic Large Cell Lymphoma
  • Lung Cancer
  • Others
Companies covered
  • Advenchen Laboratories LLC
  • Aeterna Zentaris Inc
  • Chipscreen Biosciences Ltd
  • Cielo Therapeutics Inc
  • Sareum Holdings Plc
  • AstraZeneca Plc
  • AbbVie Inc
  • Amgen Inc
  • Sanofi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Aurora Kinase B Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Aurora Kinase B Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Aurora Kinase B Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Aurora Kinase B Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Aurora Kinase B Market Dynamics
  1. 2.1 Aurora Kinase B Industry Trends
  2. 2.2 Aurora Kinase B Industry Drivers
  3. 2.3 Aurora Kinase B Industry Opportunities and Challenges
  4. 2.4 Aurora Kinase B Industry Restraints
3 Aurora Kinase B Market by Manufacturers
  1. 3.1 Global Aurora Kinase B Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Aurora Kinase B Sales by Manufacturers (2021-2026)
  3. 3.3 Global Aurora Kinase B Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Aurora Kinase B Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Aurora Kinase B Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Aurora Kinase B Manufacturers, Product Type & Application
  7. 3.7 Global Aurora Kinase B Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Aurora Kinase B Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Aurora Kinase B Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Aurora Kinase B Tier 1, Tier 2, and Tier 3
4 Aurora Kinase B Market by Type
  1. 4.1 Aurora Kinase B Type Introduction
  2. 4.1.1 Danusertib
  3. 4.1.2 NMI-900
  4. 4.1.3 Ilorasertib
  5. 4.1.4 CS-2164
  6. 4.1.5 AZD-2811
  7. 4.1.6 Others
  8. 4.2 Global Aurora Kinase B Sales by Type
  9. 4.2.1 Global Aurora Kinase B Sales by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Aurora Kinase B Sales by Type (2021-2032)
  11. 4.2.3 Global Aurora Kinase B Sales Market Share by Type (2021-2032)
  12. 4.3 Global Aurora Kinase B Revenue by Type
  13. 4.3.1 Global Aurora Kinase B Revenue by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Aurora Kinase B Revenue by Type (2021-2032)
  15. 4.3.3 Global Aurora Kinase B Revenue Market Share by Type (2021-2032)
5 Aurora Kinase B Market by Application
  1. 5.1 Aurora Kinase B Application Introduction
  2. 5.1.1 Kidney Cancer
  3. 5.1.2 Prostate Cancer
  4. 5.1.3 Anaplastic Large Cell Lymphoma
  5. 5.1.4 Lung Cancer
  6. 5.1.5 Others
  7. 5.2 Global Aurora Kinase B Sales by Application
  8. 5.2.1 Global Aurora Kinase B Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Aurora Kinase B Sales by Application (2021-2032)
  10. 5.2.3 Global Aurora Kinase B Sales Market Share by Application (2021-2032)
  11. 5.3 Global Aurora Kinase B Revenue by Application
  12. 5.3.1 Global Aurora Kinase B Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Aurora Kinase B Revenue by Application (2021-2032)
  14. 5.3.3 Global Aurora Kinase B Revenue Market Share by Application (2021-2032)
6 Global Aurora Kinase B Sales by Region
  1. 6.1 Global Aurora Kinase B Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Aurora Kinase B Sales by Region (2021-2032)
  3. 6.2.1 Global Aurora Kinase B Sales by Region (2021-2026)
  4. 6.2.2 Global Aurora Kinase B Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Aurora Kinase B Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Aurora Kinase B Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Aurora Kinase B Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Aurora Kinase B Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Aurora Kinase B Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Aurora Kinase B Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Aurora Kinase B Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Aurora Kinase B Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Aurora Kinase B Revenue by Region
  1. 7.1 Global Aurora Kinase B Revenue by Region
  2. 7.1.1 Global Aurora Kinase B Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Aurora Kinase B Revenue by Region (2021-2026)
  4. 7.1.3 Global Aurora Kinase B Revenue by Region (2027-2032)
  5. 7.1.4 Global Aurora Kinase B Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Aurora Kinase B Revenue (2021-2032)
  8. 7.2.2 North America Aurora Kinase B Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Aurora Kinase B Revenue (2021-2032)
  11. 7.3.2 Europe Aurora Kinase B Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Aurora Kinase B Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Aurora Kinase B Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Aurora Kinase B Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Aurora Kinase B Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Advenchen Laboratories LLC
  2. 8.1.1 Advenchen Laboratories LLC Company Information
  3. 8.1.2 Advenchen Laboratories LLC Business Overview
  4. 8.1.3 Advenchen Laboratories LLC Aurora Kinase B Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Advenchen Laboratories LLC Aurora Kinase B Product Portfolio
  6. 8.1.5 Advenchen Laboratories LLC Recent Developments
  7. 8.2 Aeterna Zentaris Inc
  8. 8.2.1 Aeterna Zentaris Inc Company Information
  9. 8.2.2 Aeterna Zentaris Inc Business Overview
  10. 8.2.3 Aeterna Zentaris Inc Aurora Kinase B Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Aeterna Zentaris Inc Aurora Kinase B Product Portfolio
  12. 8.2.5 Aeterna Zentaris Inc Recent Developments
  13. 8.3 Chipscreen Biosciences Ltd
  14. 8.3.1 Chipscreen Biosciences Ltd Company Information
  15. 8.3.2 Chipscreen Biosciences Ltd Business Overview
  16. 8.3.3 Chipscreen Biosciences Ltd Aurora Kinase B Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Chipscreen Biosciences Ltd Aurora Kinase B Product Portfolio
  18. 8.3.5 Chipscreen Biosciences Ltd Recent Developments
  19. 8.4 Cielo Therapeutics Inc
  20. 8.4.1 Cielo Therapeutics Inc Company Information
  21. 8.4.2 Cielo Therapeutics Inc Business Overview
  22. 8.4.3 Cielo Therapeutics Inc Aurora Kinase B Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Cielo Therapeutics Inc Aurora Kinase B Product Portfolio
  24. 8.4.5 Cielo Therapeutics Inc Recent Developments
  25. 8.5 Sareum Holdings Plc
  26. 8.5.1 Sareum Holdings Plc Company Information
  27. 8.5.2 Sareum Holdings Plc Business Overview
  28. 8.5.3 Sareum Holdings Plc Aurora Kinase B Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sareum Holdings Plc Aurora Kinase B Product Portfolio
  30. 8.5.5 Sareum Holdings Plc Recent Developments
  31. 8.6 AstraZeneca Plc
  32. 8.6.1 AstraZeneca Plc Company Information
  33. 8.6.2 AstraZeneca Plc Business Overview
  34. 8.6.3 AstraZeneca Plc Aurora Kinase B Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 AstraZeneca Plc Aurora Kinase B Product Portfolio
  36. 8.6.5 AstraZeneca Plc Recent Developments
  37. 8.7 AbbVie Inc
  38. 8.7.1 AbbVie Inc Company Information
  39. 8.7.2 AbbVie Inc Business Overview
  40. 8.7.3 AbbVie Inc Aurora Kinase B Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 AbbVie Inc Aurora Kinase B Product Portfolio
  42. 8.7.5 AbbVie Inc Recent Developments
  43. 8.8 Amgen Inc
  44. 8.8.1 Amgen Inc Company Information
  45. 8.8.2 Amgen Inc Business Overview
  46. 8.8.3 Amgen Inc Aurora Kinase B Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Amgen Inc Aurora Kinase B Product Portfolio
  48. 8.8.5 Amgen Inc Recent Developments
  49. 8.9 Sanofi
  50. 8.9.1 Sanofi Company Information
  51. 8.9.2 Sanofi Business Overview
  52. 8.9.3 Sanofi Aurora Kinase B Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Sanofi Aurora Kinase B Product Portfolio
  54. 8.9.5 Sanofi Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Aurora Kinase B Value Chain Analysis
  2. 9.1.1 Aurora Kinase B Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Aurora Kinase B Production Mode & Process
  6. 9.2 Aurora Kinase B Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Aurora Kinase B Distributors
  9. 9.2.3 Aurora Kinase B Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst